Drug profile · INN
bosutinib monohydrate
BOSULIF
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
bosutinib monohydrate (BOSULIF) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.
Key facts
INN bosutinib monohydrate
Brand BOSULIF
Route FILM COATED
Formulation CAPSULE
Frequently asked questions
What is bosutinib monohydrate?
bosutinib monohydrate (BOSULIF) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.
What is the brand name for bosutinib monohydrate?
BOSULIF is a marketed brand name for bosutinib monohydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bosutinib monohydrate?
bosutinib monohydrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.